AXGN: Axogen Inc. Stocks News on April 1, 2025

Stryker Stock Gets Relative Strength Rating Lift

AXGN

Investor's Business Daily

a day ago

Stryker Stock Gets Relative Strength Rating Lift

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN

GlobeNewswire

8 days ago

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN

Simply Wall St.

15 days ago

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75%

AXGN

MT Newswires

15 days ago

Lake Street Initiates Axogen at Buy With $30 Price Target

Alcon Stock Gets Relative Strength Rating Lift

AXGN

Investor's Business Daily

a month ago

Alcon Stock Gets Relative Strength Rating Lift

AXGN

GuruFocus.com

a month ago

Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ...

AXGN

Thomson Reuters StreetEvents

a month ago

Q4 2024 AxoGen Inc Earnings Call

AXGN

Associated Press Finance

a month ago

AxoGen: Q4 Earnings Snapshot

Axogen, Inc. To Host Analyst & Investor Day on March 4th

AXGN

GlobeNewswire

a month ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results

AXGN

GlobeNewswire

a month ago

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results

AXGN

Simply Wall St.

a month ago

We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

AXGN

GlobeNewswire

2 months ago

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN

GlobeNewswire

2 months ago

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN

Zacks

3 months ago

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?

AXGN

Zacks

3 months ago

AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AXGN

GlobeNewswire

3 months ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

AXGN

GlobeNewswire

3 months ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

AXGN

Zacks

3 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

AXGN

Zacks

3 months ago

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

AXGN

Simply Wall St.

4 months ago

Those who invested in Axogen (NASDAQ:AXGN) a year ago are up 98%

Are Medical Stocks Lagging Doximity (DOCS) This Year?

AXGN

Zacks

4 months ago

Are Medical Stocks Lagging Doximity (DOCS) This Year?

AXGN

Zacks

4 months ago

All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy

AXGN

Zacks

4 months ago

How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%

Axogen Third Quarter 2024 Earnings: Beats Expectations

AXGN

Simply Wall St.

5 months ago

Axogen Third Quarter 2024 Earnings: Beats Expectations

AxoGen Reports Strong Q3 2024 Revenue Growth

AXGN

TipRanks

5 months ago

AxoGen Reports Strong Q3 2024 Revenue Growth

AXGN

GuruFocus.com

5 months ago

Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements

AXGN

Associated Press Finance

5 months ago

AxoGen: Q3 Earnings Snapshot

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

AXGN

GlobeNewswire

5 months ago

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AXGN

GlobeNewswire

5 months ago

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

AXGN

Zacks

6 months ago

AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?

AXGN

GuruFocus.com

6 months ago

Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

AXGN

Simply Wall St.

6 months ago

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%

AXGN

Zacks

6 months ago

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

AXGN

Zacks

6 months ago

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

AXGN

Zacks

6 months ago

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

AXGN

Zacks

6 months ago

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc

AXGN

GuruFocus.com

7 months ago

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc

AXGN

Simply Wall St.

7 months ago

AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?

AXGN

MT Newswires

7 months ago

Axogen Submits Biologics License Application to US FDA for Avance Nerve Graft

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

AXGN

GlobeNewswire

7 months ago

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

AXGN

Zacks

7 months ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

AXGN

GlobeNewswire

7 months ago

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

AXGN

Zacks

7 months ago

What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?

AXGN

Zacks

7 months ago

Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?

AXGN

Zacks

7 months ago

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

AXGN

GlobeNewswire

8 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

AxoGen Second Quarter 2024 Earnings: Beats Expectations

AXGN

Simply Wall St.

8 months ago

AxoGen Second Quarter 2024 Earnings: Beats Expectations

Axogen names ex-Abbott exec Michael Dale as CEO

AXGN

MedTech Dive

8 months ago

Axogen names ex-Abbott exec Michael Dale as CEO

AXGN

MT Newswires

8 months ago

AxoGen Appoints Michael Dale as Chief Executive

AXGN

Zacks

8 months ago

AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates

AXGN

Associated Press Finance

8 months ago

AxoGen: Q2 Earnings Snapshot

Axogen, Inc. Announces New Leadership Appointments

AXGN

GlobeNewswire

8 months ago

Axogen, Inc. Announces New Leadership Appointments

Axogen, Inc. Reports Second Quarter 2024 Financial Results

AXGN

GlobeNewswire

8 months ago

Axogen, Inc. Reports Second Quarter 2024 Financial Results

AXGN

Zacks

8 months ago

AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

AXGN

GlobeNewswire

8 months ago

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

AXGN

Zacks

9 months ago

AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock?

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

AXGN

GlobeNewswire

9 months ago

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

AXGN

MT Newswires

9 months ago

Raymond James Initiates AxoGen at Outperform With $13 Price Target

AXGN

Zacks

9 months ago

AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection

AXGN

Simply Wall St.

9 months ago

The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

AXGN

GlobeNewswire

9 months ago

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

AXGN

Zacks

10 months ago

Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

AXGN

GlobeNewswire

10 months ago

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

AXGN

Zacks

10 months ago

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

AXGN

MT Newswires

a year ago

AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

AXGN

GlobeNewswire

a year ago

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

AXGN

GlobeNewswire

a year ago

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

AXGN

Insider Monkey

a year ago

AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript

AxoGen First Quarter 2024 Earnings: Misses Expectations

AXGN

Simply Wall St.

a year ago

AxoGen First Quarter 2024 Earnings: Misses Expectations

AXGN

GuruFocus.com

a year ago

Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges

AXGN

Zacks

a year ago

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

AXGN

Associated Press Finance

a year ago

AxoGen: Q1 Earnings Snapshot

Axogen, Inc Reports First Quarter 2024 Financial Results

AXGN

GlobeNewswire

a year ago

Axogen, Inc Reports First Quarter 2024 Financial Results

AXGN

Simply Wall St.

a year ago

AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

AXGN

GlobeNewswire

a year ago

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

AXGN

GlobeNewswire

a year ago

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

AXGN

Simply Wall St.

a year ago

Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long

AXGN

GuruFocus.com

a year ago

Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)

AXGN

Simply Wall St.

a year ago

US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results

AXGN

Insider Monkey

a year ago

AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript

AxoGen Full Year 2023 Earnings: Beats Expectations

AXGN

Simply Wall St.

a year ago

AxoGen Full Year 2023 Earnings: Beats Expectations

AXGN

Thomson Reuters StreetEvents

a year ago

Q4 2023 AxoGen Inc Earnings Call

AXGN

Associated Press Finance

a year ago

AxoGen: Q4 Earnings Snapshot

AXGN

GuruFocus.com

a year ago

Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

AXGN

GlobeNewswire

a year ago

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

AXGN

Zacks

a year ago

Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

AXGN

Zacks

a year ago

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

AXGN

Zacks

a year ago

AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why

AXGN

Zacks

a year ago

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

AXGN

Zacks

a year ago

Zacks.com featured highlights AxoGen, Western Digital and Gen Digital

3 Best Stocks to Buy for Remarkable Earnings Acceleration

AXGN

Zacks

a year ago

3 Best Stocks to Buy for Remarkable Earnings Acceleration

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

AXGN

GlobeNewswire

a year ago

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

AXGN

Zacks

a year ago

Here's Why Momentum in AxoGen (AXGN) Should Keep going

AXGN

Zacks

a year ago

Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

AXGN

GlobeNewswire

a year ago

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Are Investors Undervaluing Midland States Bancorp (MSBI) Right Now?

AXGN

Zacks

a year ago

Are Investors Undervaluing Midland States Bancorp (MSBI) Right Now?

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

AXGN

Zacks

a year ago

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

AXGN

Zacks

a year ago

Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group

AXGN

Zacks

a year ago

Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength

AXGN

Associated Press Finance

a year ago

Latest Axogen Inc. (AXGN) News on April 1, 2025

Share on Social Networks: